<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteGenetics &#8211; Wyss Institute</title>
		<link>https://wyss.stage.a17.io</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 30 Jul 2026 21:38:59 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.stage.a17.io/discipline/genetics/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>The Dish Live with special guest George Church</title>
				<link>https://wyss.stage.a17.io/media-post/the-dish-live-with-special-guest-george-church/</link>
        <pubDate>Thu, 02 Jan 2025 15:24:53 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[George Church]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=41759</guid>
                                                <content:encoded><![CDATA[<p>In this very special live taping of &ldquo;The Dish,&rdquo; host Johannes Fruehauf sits down with renowned geneticist and Wyss Core Faculty member, George Church, Ph.D. Widely known for discovering the first direct genomic sequencing method, Church has reshaped the world of genetics. A professor at Harvard and MIT and a founding professor at the Wyss Institute, Church has co&#x2d;founded over 50 startups&mdash;15+ of&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/the-dish-live-with-special-guest-george-church/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/the-dish-live-with-special-guest-george-church/</link>
          <title>A pioneer in CRISPR gene-editing technology, Church has been instrumental in advancing genetic research with real-world applications, including breakthroughs in organ transplantation and gene therapies. Credit: Wyss Institute at Harvard University.</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2017/01/10173821/George-Church-headshot-003.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=5039c32281e5c367e211a9075ebfb2ee"/></url>
				</image>
        			</item>

		
			<item>
				<title>SeqVerify: A New Easily Accessible Tool for Comprehensive Cell Line Quality Assessment &#8211; The Stem Cell Report</title>
				<link>https://wyss.stage.a17.io/media-post/seqverify-a-new-easily-accessible-tool-for-comprehensive-cell-line-quality-assessment-the-stem-cell-report/</link>
        <pubDate>Thu, 12 Dec 2024 16:54:17 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Computation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=41687</guid>
                                                <content:encoded><![CDATA[<p>During the last decade, advances in genome editing and pluripotent stem cell (PSC) culture have let researchers generate edited PSC lines to study a wide variety of biological questions. However, abnormalities in cell lines such as aneuploidy, mutations, on&#x2d;target and off&#x2d;target editing errors, and microbial contamination can arise during PSC culture or due to undesired editing outcomes.</p>
<p><a href="https://wyss.stage.a17.io/media-post/seqverify-a-new-easily-accessible-tool-for-comprehensive-cell-line-quality-assessment-the-stem-cell-report/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/seqverify-a-new-easily-accessible-tool-for-comprehensive-cell-line-quality-assessment-the-stem-cell-report/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/12/12115235/George-Church-Merrick-Listing-Image.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=016dad3d8050b9cf9782c3bd60bfa898"/></url>
				</image>
        			</item>

		
			<item>
				<title>CRISPR&#8217;s Impact, Today</title>
				<link>https://wyss.stage.a17.io/news/crisprs-impact-today/</link>
        <pubDate>Mon, 21 Oct 2024 12:00:08 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[Editas Inc.]]></category>
		<category><![CDATA[eGenesis]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Massachusetts General Hospital]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40926</guid>
                            <description>Keeping CRISPR’s promise for patients in need</description>
                                        <content:encoded><![CDATA[<p>By Seth Kroll (BOSTON) &mdash; In the not&#x2d;so&#x2d;distant past, CRISPR, the revolutionary gene&#x2d;editing technology, was discovered as a defense system protecting bacteria against viruses. Today, with the persistence and ingenuity of many scientists, it is no longer just the subject of fascinating academic research papers and speculative discussions on its future usefulness for medicine.</p>
<p><a href="https://wyss.stage.a17.io/news/crisprs-impact-today/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/crisprs-impact-today/</link>
          <title>Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. CREDITS: Michelle Rose/Massachusetts General Hospital</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/09/09093712/20240403_mcr_transplant_patient_010-1.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=911871f7428259dbd6ffadedb29de92e"/></url>
				</image>
        			</item>

		
			<item>
				<title>“Suspended animation” drug could aid organ transplantation and survival from traumatic injury</title>
				<link>https://wyss.stage.a17.io/news/suspended-animation-drug-could-aid-organ-transplantation-and-survival-from-traumatic-injury/</link>
        <pubDate>Tue, 24 Sep 2024 14:50:33 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biostasis]]></category>
		<category><![CDATA[DARPA]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Injectable]]></category>
		<category><![CDATA[Metabolic Engineering]]></category>
		<category><![CDATA[Tissue Regeneration]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=39093</guid>
                            <description>Study suggests that a pain relief drug can quickly and reversibly induce a sleep-like state in cells and organs could facilitate organ transplantation and prevent irreversible tissue injury</description>
                                        <content:encoded><![CDATA[<p>(CAMBRIDGE, UK) &ndash; Researchers have shown that a non&#x2d;addictive pain relief drug could be used to preserve cells and organs quickly and safely for transplantation, removing the need for static cold storage. The research, published today in eLife, was described by the editors as an important study providing solid evidence that the existing drug, SNC80, can rapidly and reversibly slow biochemical&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/suspended-animation-drug-could-aid-organ-transplantation-and-survival-from-traumatic-injury/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/suspended-animation-drug-could-aid-organ-transplantation-and-survival-from-traumatic-injury/</link>
          <title>Caption. Credit: Envato/Chalabala</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/02/05152449/emergency-medical-service-2023-11-27-04-57-42-utc.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=d122e344c2692b34c68f3e8dffa33317"/></url>
				</image>
        			</item>

		
			<item>
				<title>Alex Plesa on Reversing Aging</title>
				<link>https://wyss.stage.a17.io/news/humans-of-the-wyss-alex-plesa-on-reversing-aging/</link>
        <pubDate>Thu, 30 May 2024 13:00:18 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Cardiovascular Dysfunction]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40026</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Most people believe that declining health as we age is an unfortunate, inevitable fact of life &ndash; but not Alex Plesa. He thinks the reason we think we can&rsquo;t change it is because we don&rsquo;t&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/humans-of-the-wyss-alex-plesa-on-reversing-aging/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/humans-of-the-wyss-alex-plesa-on-reversing-aging/</link>
          <title>Alex Plesa, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/05/28094559/Alex-Plesa-07200.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=811e245d112be9f293681e9a1f16b2a5"/></url>
				</image>
        			</item>

		
			<item>
				<title>Engineered Live Biotherapeutic Product (eLBP) to Protect the Microbiome from Antibiotics</title>
				<link>https://wyss.stage.a17.io/technology/engineered-live-biotherapeutic-product-elbp-to-protect-the-microbiome-from-antibiotics/</link>
        <pubDate>Wed, 01 May 2024 14:44:43 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Antibiotic Resistance]]></category>
		<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[Pathogen]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=32666</guid>
                                                <content:encoded><![CDATA[<p>Antibiotics not only kill the pathogenic bacteria causing an infection, they also indiscriminately wreak havoc on the trillions of &ldquo;good&rdquo; bacteria making up the human microbiome. Known as &ldquo;dysbiosis,&rdquo; this alteration of our gut microbial composition manifests as discomforting diarrhea in up to 35% of patients in the short term, and can take months to resolve, often requiring dietary corrections&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/engineered-live-biotherapeutic-product-elbp-to-protect-the-microbiome-from-antibiotics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/engineered-live-biotherapeutic-product-elbp-to-protect-the-microbiome-from-antibiotics/</link>
          <title>Adobe Stock / Design Cells</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/04/08113739/AdobeStock_384900840.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=cde2ed85aed37e5d2812ff36986732f4"/></url>
				</image>
        			</item>

		
			<item>
				<title>Paper-Based Diagnostics</title>
				<link>https://wyss.stage.a17.io/technology/paper-based-diagnostics/</link>
        <pubDate>Wed, 01 May 2024 00:34:41 +0000</pubDate>
        <dc:creator><![CDATA[admin]]></dc:creator>
        		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[Paper-based Diagnostics]]></category>
		<category><![CDATA[Paper-based Sensors]]></category>
		<category><![CDATA[RNA]]></category>
		<category><![CDATA[Zika]]></category>
				<guid isPermaLink="false">https://wyss.prod.a17.io/technology/paper-based-sensors/</guid>
                                                <content:encoded><![CDATA[<p>With the imminent threat of new pandemics and frequent disease outbreaks exemplified by the recent Ebola and Zika epidemics, there is a growing need for low&#x2d;cost, easily deployable and simple&#x2d;to&#x2d;use diagnostic tools. The Wyss Institute has developed paper&#x2d;based synthetic gene networks as a next generation diagnostic technology for use in global healthcare crises and patient care. This new type of&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/paper-based-diagnostics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/paper-based-diagnostics/</link>
          <title>A black cartridge containing a paper-based diagnostic for detecting the Zika virus is held up by a researcher at Harvard's Wyss Institute. Areas that have turned purple indicate samples infected with Zika, while yellow areas indicate samples that are free of the virus. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2016/08/08125624/Paper-based-results-002.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=caa2a0698d47a3b11ede1dd28836ae4a"/></url>
				</image>
        			</item>

		
			<item>
				<title>HarborSite Animation</title>
				<link>https://wyss.stage.a17.io/media-post/harborsite-animation/</link>
        <pubDate>Mon, 18 Mar 2024 13:59:40 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[George Church]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=39429</guid>
                                                <content:encoded><![CDATA[<p>This animation explains how the Wyss Institute&rsquo;s HarborSite genome editing technology uses highly specific and efficient recombinase enzymes and genomic safe harbors to achieve more predictable, safe, and durable gene therapies. Credit: Wyss Institute at Harvard University&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/harborsite-animation/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/harborsite-animation/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/03/12165151/title-page.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=48b4f9047501fc1e067f1e8c5e281846"/></url>
				</image>
        			</item>

		
			<item>
				<title>Highly Cited Researchers 2023 honors 13 Wyss faculty members</title>
				<link>https://wyss.stage.a17.io/news/highly-cited-researchers-2023-honors-13-wyss-faculty-members/</link>
        <pubDate>Wed, 15 Nov 2023 14:00:32 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Bioinspired Engineering]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Conor Walsh]]></category>
		<category><![CDATA[David A. Weitz]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
		<category><![CDATA[Kevin Kit Parker]]></category>
		<category><![CDATA[Peng Yin]]></category>
		<category><![CDATA[Rob Wood]]></category>
		<category><![CDATA[Samir Mitragotri]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=38298</guid>
                            <description>The annual award celebrates the top 1% of researchers by paper citations over the last decade</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; Today, Clarivate Analytics announced its annual Highly Cited Researchers 2023 list, which honors the top 1% of researchers around the world whose papers have been cited the most in the previous 10 years. Clarivate uses both quantitative and qualitative analyses to identify individuals who have demonstrated significant and broad influence in their chosen field(s)&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/highly-cited-researchers-2023-honors-13-wyss-faculty-members/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/highly-cited-researchers-2023-honors-13-wyss-faculty-members/</link>
          <title>12 Wyss Faculty and staff members were among the most highly cited researchers. Credit: Shutterstock/PopTika </title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/11/13163826/shutterstock_1006041130.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=138217f17cd9c0f5c54e2e5618df8731"/></url>
				</image>
        			</item>

		
			<item>
				<title>Probiotic pills packed with an unexpected punch</title>
				<link>https://wyss.stage.a17.io/news/probiotic-pills-packed-with-an-unexpected-punch/</link>
        <pubDate>Mon, 23 Oct 2023 17:14:14 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[George Church]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=38053</guid>
                            <description>Wyss Lumineer Jonathan Scheiman, Founder and CEO of Wyss startup FitBiomics, reflects on his journey from being a college athlete to a Wyss postdoc to the leader of a successful biotech company </description>
                                        <content:encoded><![CDATA[<p>By Jessica Leff Elite athletes are as rare as centenarians: both groups make up about 0.01% of the human population. This begs the question: what is unique about these super performers/the super fit, and can we use that information to improve the health of all humans throughout their lifespan? That was the central idea behind the sports genomics project at the Wyss Institute&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/probiotic-pills-packed-with-an-unexpected-punch/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/probiotic-pills-packed-with-an-unexpected-punch/</link>
          <title>Jonathan Scheiman, Ph.D., co-founded FitBiomics with Wyss Core Faculty member George Church, Ph.D. to commercialize performance-boosting probiotics identified from the microbiomes of elite athletes. FitBiomics' first product, Nella, was launched in 2021 and counts many professional and amateur athletes among its users. Credit: Jonathan Scheiman</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/10/19153637/JonathanSListing.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=ef532b4db0791f9de666138603bf186e"/></url>
				</image>
        			</item>

			</channel>
</rss>
